Results 21 to 30 of about 331,825 (303)

Outcomes and Therapeutic Management of Bladder Cancer [PDF]

open access: yes, 2020
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection ...

core   +1 more source

Quality of Life and Health State Utilities in Bladder Cancer

open access: yes, 2022
Background: Bladder cancer treatments may variably impact health-related quality of life (QOL). Objective: To characterize the quality of life of patients with bladder cancer at various time points across the continuum of bladder cancer care from non ...
Amy Guo   +17 more
core   +1 more source

The call for a strategic framework to improve cancer literacy in Europe

open access: yesArchives of Public Health, 2020
Background Health literacy is increasingly being recognized as a widespread public health challenge in Europe. This commentary explores the importance of health literacy amongst cancer patients (ie, cancer literacy) and examines how cancer literacy can ...
Kristine Sørensen   +6 more
doaj   +1 more source

Intrinsic subtypes and bladder cancer metastasis

open access: yesAsian Journal of Urology, 2016
Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics.
David J. McConkey   +3 more
doaj   +1 more source

Human urinary exosomes in bladder cancer patients : properties, concentrations and possible clinical application

open access: yes, 2015
OBJECTIVE: High grade bladder cancer is extremely aggressive. Early detection is thus an important challenge. De- velopment of non-invasive diagnostic tools particularly using urine samples could be of importance in the diagnosis and surveillance of ...
Mullen, Peter   +11 more
core   +1 more source

Measurements of complement factor H-related protein (BTA-TRAK (TM) assay) and nuclear matrix protein (NMP22 assay) - Useful diagnostic tools in the diagnosis of urinary bladder cancer? [PDF]

open access: yes, 2003
Between 1997 and 2000 we investigated in a prospective study the voided urine samples of all consecutive patients undergoing cystoscopy independent from their clinical background (n=705) with the BTA-TRAK(TM) assay (Bard Diagnostics, Redmont, USA ...
Holdenrieder, Stefan   +17 more
core   +1 more source

Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma

open access: yesDiagnostics
Background/Objectives: Clear-cell renal cell carcinoma (ccRCC) represents the predominant histologic subtype of renal cancer and poses persistent diagnostic challenges, particularly in the evaluation of small renal masses, where conventional imaging and ...
Daniel A. González-Padilla   +14 more
doaj   +1 more source

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression [PDF]

open access: yes, 2009
Background: New methods for identifying bladder cancer (BCa) progression are required. Gene expression microarrays can reveal insights into disease biology and identify novel biomarkers.
Wild, P J   +50 more
core   +1 more source

Bladder-to-bladder metastasis: gallbladder cancer metastasising to the urinary bladder

open access: yes, 2021
We report a 48-year-old fit and healthy woman who was incidentally diagnosed to have adenocarcinoma of gallbladder after laparoscopic cholecystectomy. Subsequent imaging showed no evidence of regional or distant spread.
J. Abbaraju   +3 more
core   +1 more source

Bladder Cancer [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2013
Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of ...
Peter E, Clark   +26 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy